Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-ERG Antibody (R1A45)

Catalog #:   RHC87802 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IF, IHC, ChIP, WB
Accession: P11308
Overview

Catalog No.

RHC87802

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IF: 1:50-1:200, IHC: 1:100-1:200, ChIP: 1:20-1:50, WB: 1:1000-1:2000

Target

ERG, erg-3, p55, KCNH2, ERG

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P11308

Applications

IF, IHC, ChIP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4 ℃ short term (1-2 weeks). Store at -20 ℃ 12 months. Store at -80 ℃ long term.

Clone ID

R1A45

Data Image
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded human kidney, using ERG Antibody.
  • Western blot
    All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.
  • Western blot
    All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.
  • Western blot
    Western blot analysis of ERG expression in HeLa cell lysate.
References

Oxidative DNA Damage Drives Apoptotic Photoreceptor Loss in NMNAT1 -Associated Inherited Retinal Degeneration: A Therapeutic Opportunity., PMID:40501637

Computational design of therapeutic antibodies with improved developability: efficient traversal of binder landscapes and rescue of escape mutations., PMID:40458889

Paraneoplastic autoimmune retinopathy associated with anti-enolase antibodies in a patient with lung cancer remission., PMID:40398460

PD - L1 (SP263) expression correlates with pathological aggressive parameters in prostate cancer., PMID:40273724

Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin., PMID:40252634

A seven-year electroretinography follow-up of a patient with melanoma-associated retinopathy stabilized on pembrolizumab treatment., PMID:40230455

Guidelines for the Diagnosis, Management, and Study of Autoimmune Retinopathy from the American Academy of Ophthalmology's Task Force., PMID:40180315

Case of uveitis with increased electroretinographic amplitudes following Nivolumab and Ipilimumab administration for malignant melanoma., PMID:40072695

Rational design of cyclic peptides, with an emphasis on bicyclic peptides., PMID:40068542

Intravitreal delivery of NMO-IgG causes primary retinal damage in the absence of optic nerve injury., PMID:40055743

Genetic mutation in HSF4 is associated with retinal degeneration in mice., PMID:40023307

The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape., PMID:39965084

Cancer Associated Retinopathy Related to Gastrointestinal Stromal Tumor of Stomach: Case Report., PMID:39951621

Endovenous treatment for varicose veins of the lower limbs: Comparative histological evaluation of different techniques., PMID:39614777

Differential Localization and Functional Roles of mGluR6 Paralogs in Zebrafish Retina., PMID:39475940

Accelerating histopathology workflows with generative AI-based virtually multiplexed tumour profiling., PMID:39309216

Plasma exchange-sensitive syncytial glomerulopathy in a kidney transplant patient., PMID:39162815

Defining angioinvasion and lymphatic invasion in papillary thyroid carcinoma: morphological criteria, utility of D2-40/CD31/ERG immunohistochemistry and correlation with clinicopathological characteristics., PMID:39030854

Circadian rhythms in the Drosophila eye may regulate adaptation of vision to light intensity., PMID:38872947

Tislelizumab combined with GT chemotherapy for intimal sarcoma of inferior vena cava: A case report., PMID:38788046

Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study., PMID:38575338

Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma., PMID:38477966

Acantholytic squamous cell carcinoma mimicking epithelioid angiosarcoma: A diagnostic challenge by cytology., PMID:38069674

Short peptides derived from pigment epithelium-derived factor attenuate retinal ischemia reperfusion injury through inhibition of apoptosis and inflammatory response in rats., PMID:38056550

Unilateral Melanoma-Associated Retinopathy Case Report., PMID:37901652

The Usefulness of Elastin Staining to Detect Vascular Invasion in Cancer., PMID:37894944

Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues., PMID:37892063

Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C., PMID:37870968

Transferrin Receptor-Targeted Iduronate-2-sulfatase Penetrates the Blood-Retinal Barrier and Improves Retinopathy in Mucopolysaccharidosis II Mice., PMID:37860991

Integrated single-cell and spatial transcriptomics reveals heterogeneity of fibroblast and pivotal genes in psoriasis., PMID:37816883

Safety and Efficacy of Oral Hydroxychloroquine in the Treatment of Ophthalmic Disease Associated with Sjögren's Syndrome., PMID:37678871

A case of cutaneous malignant glomus tumor., PMID:37661598

Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study., PMID:37642075

Caspase-9 inhibition confers stronger neuronal and vascular protection compared to VEGF neutralization in a mouse model of retinal vein occlusion., PMID:37449272

Development and characterization of an ETV1 rabbit monoclonal antibody for the immunohistochemical detection of ETV1 expression in cancer tissue specimens., PMID:37196930

Electroretinographic Responses in Retinopathy of Prematurity Treated Using Intravitreal Bevacizumab or Laser., PMID:37146743

Serum antiretinal antibodies and cytokine profiling in autoimmune retinopathy and their association with clinical outcomes., PMID:37099128

Micro-abnormalities in the retina and choroid induced by anti-CTLA4 treatment., PMID:37072549

Endothelial Cell Markers Are Inferior to Vascular Smooth Muscle Cells Markers in Staining Vasa Vasorum and Are Non-Specific for Distinct Endothelial Cell Lineages in Clinical Samples., PMID:36768296

Clinical impact of ERG and PTEN status in prostate cancer patients underwent radical prostatectomy., PMID:36576468

Functional Changes in the Adult Mouse Retina using an Alpha7 Nicotinic Acetylcholine Receptor Agonist after Blast Exposure., PMID:36572172

Electrophysiological Evaluation of Macular Photoreceptor Functions in Patients with Choroidal Neovascular Membranes., PMID:36524692

Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma., PMID:36362420

The Developmental Progression of Eight Opsin Spectral Signals Recorded from the Zebrafish Retinal Cone Layer Is Altered by the Timing and Cell Type Expression of Thyroxin Receptor β2 (trβ2) Gain-Of-Function Transgenes., PMID:36351817

Melanoma-associated retinopathy with anti-TRPM1 autoantibodies showing concomitant Off-bipolar cell dysfunction., PMID:36173494

Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumors., PMID:36137400

B7-H3 as a Therapeutic Target in Advanced Prostate Cancer., PMID:36114082

Antireconverin antibodies in ocular chronic graft versus host disease: A new cause of nonparaneoplasic autoimmune retinopathy., PMID:36052416

Autoimmune Retinopathy Caused by Anti-Paraneoplastic Antigen MA2: A Case Study., PMID:35811772

Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal., PMID:35802295

Datasheet

Document Download

Anti-ERG Antibody (R1A45).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-ERG Antibody (R1A45) [RHC87802]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only